cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kala Pharmaceuticals Inc
41 own
56 watching
Current Price
$17.58
$-0.47
(-2.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
25.96M
52-Week High
52-Week High
97
52-Week Low
52-Week Low
3.5444
Average Volume
Average Volume
0.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization25.96M
icon52-Week High97
icon52-Week Low3.5444
iconAverage Volume0.11M
iconDividend Yield--
iconP/E Ratio--
What does the Kala Pharmaceuticals Inc do?
N/A
Read More
How much money does Kala Pharmaceuticals Inc make?
News & Events about Kala Pharmaceuticals Inc.
PR Newswire
1month ago
Thinking about buying stock in Palisade Bio, Kala Pharmaceuticals, F-Star Therapeutics, Nuwellis, or TG Therapeutics? Thinking about buying stock in Palisade Bio, Kala Pharmaceuticals, F-Star Therapeutics, Nuwellis, or TG Therapeutics? PR Newswire NEW YORK, Dec. 30, 2022 NEW YORK, Dec. 30, 2022...
PR Newswire
1month ago
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030 Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030 PR Newswire Palm Beach, Fla., Dec. 30, 2022 FinancialNewsMedia.com News Commentary Palm Beach, Fla., Dec. 30, 2022 /PRNewswire...
PR Newswire
1month ago
Thinking about buying stock in Baudax Bio, Kala Pharmaceuticals, GlycoMimetics, Pagaya Technologies, or Transcode Therapeutics? Thinking about buying stock in Baudax Bio, Kala Pharmaceuticals, GlycoMimetics, Pagaya Technologies, or Transcode Therapeutics? PR Newswire NEW YORK, Dec. 29, 2022 NEW...
Benzinga
1month ago
With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: read more...
InvestorPlace
1month ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kala Pharmaceuticals easily stole the show with a blistering midweek performance, though longer-term challenges remain for KALA stock. The post Why Is Kala Pharmaceuticals (KALA) Stock Soaring 240%? appeared first on InvestorPlace...
Frequently Asked Questions
Frequently Asked Questions
What is Kala Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Kala Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Kala Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Kala Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kala Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Kala Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Kala Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kala Pharmaceuticals Inc?
plus_minus_icon
What percentage is Kala Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kala Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$17.58
$-0.47
(-2.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
MEDAVAIL HOLDINGS INC
MEDAVAIL HOLDINGS INC
$0.37
$-0.01 (-1.87 %)
Finch Therapeutics Group Inc
Finch Therapeutics Group Inc
$0.52
$0.03 (5.35 %)
Angion Biomedica Corp
Angion Biomedica Corp
$0.67
$0.00 (0.00 %)
Humanigen Inc
Humanigen Inc
$0.19
$0.01 (4.78 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
MEDAVAIL HOLDINGS INC
MEDAVAIL HOLDINGS INC
$0.37
$-0.01 (-1.87 %)
Finch Therapeutics Group Inc
Finch Therapeutics Group Inc
$0.52
$0.03 (5.35 %)
Angion Biomedica Corp
Angion Biomedica Corp
$0.67
$0.00 (0.00 %)
Humanigen Inc
Humanigen Inc
$0.19
$0.01 (4.78 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00